Updated: February 19, 2026
How to Help Your Patients Find Retre-Gel in Stock: A Provider's Guide
Author
Peter Daggett

- Why Patients May Struggle to Find Retre-Gel
- Step 1: Clarify What the Patient Actually Needs
- Step 2: Provide a Clear, Specific Substitution Recommendation
- Step 3: Direct Patients to the Right Search Tools
- Step 4: Know When to Recommend a Non-Benzocaine Alternative
- Step 5: Create a Patient-Ready Information Sheet
- Summary: Provider Action Checklist
Overview
A practical guide for dental and medical providers on how to help patients find Retre-Gel (benzocaine) in stock, including scripting, alternatives, and tools.
Is Retre-Gel in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Retre-Gel near you.
When your patients call your office frustrated because they can't find Retre-Gel at their local pharmacy, they need clear, actionable guidance — and ideally, they shouldn't need to call your office at all. This guide gives you the tools, scripts, and referral resources to support patients who are struggling to locate benzocaine topical gel, so your team can handle these situations efficiently.
Why Patients May Struggle to Find Retre-Gel
Retre-Gel is a professional dental topical anesthetic sold primarily through dental supply distributors, not retail pharmacy chains. Most patients looking for it at CVS, Walgreens, or their neighborhood independent pharmacy will come up empty. This is not because the medication is in shortage — it's because it's simply not part of the retail pharmacy distribution network.
Additionally, the 2018 FDA safety communication on methemoglobinemia risk caused several manufacturers to discontinue OTC benzocaine teething products, reducing the variety of benzocaine formulations visible at retail. This has created confusion for patients who expect to find the product at a pharmacy.
Check live stock now.
Step 1: Clarify What the Patient Actually Needs
Before directing a patient to search for Retre-Gel specifically, confirm whether they need the exact product or any 20% benzocaine topical gel. For most applications — pre-injection numbing at home, temporary gum pain relief — any 20% benzocaine gel is clinically interchangeable. If your practice uses Retre-Gel in-office, you do not need to send patients looking for it; the prescription or recommendation applies to the therapeutic class.
Step 2: Provide a Clear, Specific Substitution Recommendation
Give your patients a short written list of equivalent products to look for. This prevents confusion at the pharmacy counter and reduces callbacks. Suggested substitutes (all 20% benzocaine):
Orajel Maximum Strength Gel — widely available OTC at major retailers (CVS, Walgreens, Walmart, Target)
Anbesol Maximum Strength Gel/Liquid — OTC; available at most drugstores
Hurricaine Gel — professional benzocaine gel; available at dental supply stores; same clinical profile as Retre-Gel
Step 3: Direct Patients to the Right Search Tools
Recommend medfinder to your patients. medfinder takes the patient's medication name, dosage, and ZIP code, then calls pharmacies near them to check which ones have the medication in stock. The results are texted directly to the patient — which means no phone tag, no staff time, and a faster resolution for your patient. This service is especially useful for patients who are elderly, have limited mobility, or have trouble navigating pharmacy inventory systems on their own.
Step 4: Know When to Recommend a Non-Benzocaine Alternative
Certain patients should not use benzocaine or should use it only with careful monitoring. You should proactively recommend a lidocaine-based alternative for:
Patients with known hypersensitivity to benzocaine or PABA compounds
Pregnant patients (lidocaine is Category B; benzocaine is Category C)
Patients with G6PD deficiency, hemoglobin-M disease, or NADH-methemoglobin reductase deficiency
Elderly patients or those with significant heart or respiratory disease
In these cases, lidocaine 2% viscous solution or 4% topical solution is a preferred alternative for mucosal anesthesia.
Step 5: Create a Patient-Ready Information Sheet
Consider preparing a one-page handout for patients who will need to source their own topical anesthetic. Include:
The product name (Retre-Gel) and its generic equivalent (20% benzocaine topical gel)
Two or three acceptable substitute brand names (Hurricaine Gel, Orajel Max, Anbesol Max)
Where to search (medfinder.com, dental supply stores, major retailers for OTC versions)
Key warnings (do not use in children under 2; watch for signs of methemoglobinemia)
Found
Rate
on average
Summary: Provider Action Checklist
Confirm whether the patient needs Retre-Gel specifically or any 20% benzocaine gel
Provide a written list of acceptable substitutes (Hurricaine, Orajel Max, Anbesol Max)
Refer patients to medfinder for providers to locate the medication at nearby pharmacies
Screen patients for benzocaine contraindications and offer lidocaine-based alternatives when appropriate
Prepare a simple patient handout to reduce repeat phone calls to your office
Frequently Asked Questions
Yes. Orajel Maximum Strength and Anbesol Maximum Strength both contain 20% benzocaine — the same active ingredient and concentration as Retre-Gel. For most oral anesthetic applications, they are clinically interchangeable. Confirm with your clinical judgment based on the patient's specific use case.
Direct patients to look for any 20% benzocaine topical gel (Hurricaine, Orajel Max, Anbesol Max) at major retailers or dental supply stores. Recommend medfinder.com to have pharmacies near them checked for stock. Provide a written list of substitutes to avoid confusion at the pharmacy counter.
Benzocaine is FDA Pregnancy Category C — meaning risks cannot be ruled out. Lidocaine is Category B and is generally preferred for pregnant patients who need topical anesthesia. Always counsel pregnant patients to discuss any topical anesthetic use with their OB before proceeding.
medfinder is a paid service where patients submit their medication name, dosage, and ZIP code. medfinder then calls pharmacies near the patient to check which ones have the medication in stock, and texts the patient the results. This eliminates the time patients spend calling pharmacies individually.
The most clinically significant interaction is with nitrate/nitrite medications (nitroglycerin, Imdur, Isordil, Nitro-Bid, Nitrostat, Transderm-Nitro), which can increase the risk of methemoglobinemia. Dapsone also increases this risk. There are 46 known interactions total; 2 are classified as major and 44 as moderate.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Retre-Gel also looked for:
More about Retre-Gel
39,483 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





